Akari Therapeutics's three largest insider shareholders as of June 12, 2026 are Samir Rashmikant Patel (Director, 5.25Bn shares), Raymond Prudo-Chlebosz (Director, 4.08Bn shares), Rachelle Suzanne Jacques (Chief Executive Officer, 1.02Bn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Wendy F Dicicco | Interim Cfo | 158,473,915 | 0 | 03 May, 2024 |
| Hoyoung Huh | - | 4,695,854 | 0 | 10 Mar, 2025 |
| James R Neal | - | 32,216,000 | 0 | 10 Jan, 2025 |
| Robert B Bazemore | - | 44,642 | 0 | 10 Mar, 2025 |
| Raymond Prudo-Chlebosz | - | 4,077,124,600 | 0 | 03 Dec, 2024 |
| Samir Rashmikant Patel | - | 0 | 5,249,511,500 | 07 Jan, 2025 |
| Rachelle Suzanne Jacques | Chief Executive Officer | 1,018,027,792 | 0 | 30 Apr, 2024 |
| Sandip I Patel | - | 496,499 | 0 | 29 Apr, 2025 |
| Torsten Hombeck | Cfo | 200 | 0 | 13 Jan, 2025 |
| Abizer Gaslightwala | - | 71,720,000 | 0 | 07 Jan, 2025 |
| Kameel D. Farag | Interim Cfo | 26,619 | 0 | 04 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Dec, 2025 | Sandip I Patel | Warrants to purchase American Depositary Shares (ADRs) | A | 247,462 | - | 247,462 | D | P |
| 16 Dec, 2025 | Raymond Prudo-Chlebosz | Warrants to purchase American Depositary Shares (ADRs) | A | 618,658 | - | 618,658 | D | P |
| 16 Dec, 2025 | Samir Rashmikant Patel | Warrants to purchase American Depositary Shares (ADRs) | A | 618,658 | - | 618,658 | D | P |
| 16 Dec, 2025 | Hoyoung Huh | Warrants to purchase American Depositary Shares (ADRs) | A | 618,658 | - | 618,658 | D | P |
| 16 Dec, 2025 | Raymond Prudo-Chlebosz | Warrants to purchase American Depositary Shares (ADRs) | A | 618,658 | - | 618,658 | D | P |
| 16 Dec, 2025 | Kameel D. Farag | Warrants to purchase American Depositary Shares (ADRs) | A | 24,745 | - | 24,745 | D | P |
| 16 Dec, 2025 | Abizer Gaslightwala | Warrants to purchase American Depositary Shares (ADRs) | A | 309,328 | - | 309,328 | D | P |
| 16 Dec, 2025 | Abizer Gaslightwala | Warrants to purchase American Depositary Shares (ADRs) | A | 309,328 | - | 309,328 | D | P |
| 16 Dec, 2025 | Samir Rashmikant Patel | Warrants to purchase American Depositary Shares (ADRs) | A | 618,658 | - | 618,658 | D | P |
| 16 Dec, 2025 | Kameel D. Farag | Warrants to purchase American Depositary Shares (ADRs) | A | 24,745 | - | 24,745 | D | P |
| 16 Dec, 2025 | Robert B Bazemore | Warrants to purchase American Depositary Shares (ADRs) | A | 123,731 | - | 123,731 | D | P |
| 16 Dec, 2025 | Samir Rashmikant Patel | Pre-Funded Warrants to purchase ADRs | A | 618,658 | $0.40 | 618,658 | D | P |
| 16 Dec, 2025 | Samir Rashmikant Patel | Pre-Funded Warrants to purchase ADRs | A | 618,658 | $0.40 | 618,658 | D | P |
| 16 Dec, 2025 | Raymond Prudo-Chlebosz | Pre-Funded Warrants to purchase ADRs | A | 618,658 | $0.40 | 618,658 | D | P |
| 16 Dec, 2025 | Kameel D. Farag | Pre-Funded Warrants to purchase ADRs | A | 24,745 | $0.40 | 24,745 | D | P |
| 16 Dec, 2025 | Abizer Gaslightwala | Pre-Funded Warrants to purchase ADRs | A | 309,328 | $0.40 | 309,328 | D | P |
| 16 Dec, 2025 | Kameel D. Farag | Pre-Funded Warrants to purchase ADRs | A | 24,745 | $0.40 | 24,745 | D | P |
| 16 Dec, 2025 | Abizer Gaslightwala | Pre-Funded Warrants to purchase ADRs | A | 309,328 | $0.40 | 309,328 | D | P |
| 16 Dec, 2025 | Robert B Bazemore | Pre-Funded Warrants to purchase ADRs | A | 123,731 | $0.40 | 123,731 | D | P |
| 16 Dec, 2025 | Sandip I Patel | Pre-Funded Warrants to purchase ADRs | A | 247,462 | $0.40 | 247,462 | D | P |